Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

Seven warning signs of pancreatic cancer you shouldn't ignore as these subtle symptoms often get dismissed but could save ...

The U.S. Food and Drug Administration has approved Regeneron's cancer therapy, the company said on Wednesday, providing ...

A 2022 study claims to have found that a certain blood type is linked to a higher risk of colorectal cancer. Colorectal ...

Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared.

Researchers have identified ways in which chemotherapy can damage healthy cells and found that some drugs can add decades of ...

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to ...

A routine blood test may be able to detect cancer more than three years before diagnosis, a new study suggests. In the study, ...

To develop the test, researchers analyzed 6553 blood samples, 3076 from patients with cancer and 3477 from healthy ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.